Molecular Partners AG
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MOLN and other ETFs, options, and stocks.About MOLN
Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs.
CEOPatrick Amstutz
CEOPatrick Amstutz
Employees174
Employees174
HeadquartersSchlieren, Zurich
HeadquartersSchlieren, Zurich
Founded2004
Founded2004
Employees174
Employees174
MOLN Key Statistics
Market cap174.35M
Market cap174.35M
Price-Earnings ratio-2.22
Price-Earnings ratio-2.22
Dividend yield—
Dividend yield—
Average volume4.07K
Average volume4.07K
High today$4.26
High today$4.26
Low today$3.98
Low today$3.98
Open price$4.20
Open price$4.20
Volume3.38K
Volume3.38K
52 Week high$5.91
52 Week high$5.91
52 Week low$3.36
52 Week low$3.36
Stock Snapshot
With a market cap of 174.35M, Molecular Partners AG(MOLN) trades at $4.26. The stock has a price-to-earnings ratio of -2.22.
On 2025-12-18, Molecular Partners AG(MOLN) stock traded between a low of $3.98 and a high of $4.26. Shares are currently priced at $4.26, which is +7.0% above the low and 0.0% below the high.
The Molecular Partners AG(MOLN)'s current trading volume is 3.38K, compared to an average daily volume of 4.07K.
During the past year, Molecular Partners AG(MOLN) stock moved between $3.36 at its lowest and $5.91 at its peak.
During the past year, Molecular Partners AG(MOLN) stock moved between $3.36 at its lowest and $5.91 at its peak.
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%